Cellebrite DI Ltd. (CLBT)
24.17
1.17 (5.09%)
At close: Jan 28, 2025, 3:00 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -81.10M | 120.81M | 71.40M | 5.78M | -1.88M |
| Depreciation & Amortization | 10.01M | 9.19M | 7.09M | 5.88M | 4.08M |
| Stock-Based Compensation | 19.00M | 13.71M | 6.48M | 7.27M | 12.76M |
| Other Working Capital | 31.58M | 19.22M | 20.19M | 71.63M | 13.16M |
| Other Non-Cash Items | 110.50M | -117.92M | -67.86M | 626.00K | 131.00K |
| Deferred Income Tax | 5.13M | -2.39M | -1.64M | -2.82M | -1.67M |
| Change in Working Capital | 38.52M | -2.82M | 20.59M | 49.77M | 2.71M |
| Operating Cash Flow | 102.06M | 20.58M | 36.05M | 66.51M | 16.13M |
| Capital Expenditures | -7.92M | -9.09M | -8.11M | -6.18M | -6.21M |
| Acquisitions | n/a | 106.61M | -20.00M | -15.05M | n/a |
| Purchase of Investments | -55.32M | -165.36M | -21.00M | -138.50M | n/a |
| Sales Maturities Of Investments | 56.34M | 83.22M | 94.34M | 153.28M | n/a |
| Other Investing Acitivies | -15.64M | -106.61M | 70.34M | 14.78M | -40.51M |
| Investing Cash Flow | -22.54M | -91.23M | 45.23M | -6.45M | -46.72M |
| Debt Repayment | n/a | n/a | n/a | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | -85.00K | -808.00K |
| Dividend Paid | n/a | n/a | -100.00M | -10.00M | -25.00M |
| Other Financial Acitivies | 21.77M | 13.97M | 31.60M | 1.49M | 101.35M |
| Financial Cash Flow | 21.77M | 13.97M | -68.40M | -8.59M | 75.54M |
| Net Cash Flow | 101.87M | -58.33M | 12.13M | 52.16M | 44.88M |
| Free Cash Flow | 94.14M | 11.49M | 27.94M | 60.33M | 9.92M |